{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:40:06Z","timestamp":1780735206822,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-024-06120-0","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:53:20Z","timestamp":1736978000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-222X","authenticated-orcid":false,"given":"Claudia","family":"Sossa-Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-4041","authenticated-orcid":false,"given":"Virginia","family":"Abello-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-937X","authenticated-orcid":false,"given":"Luis A.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1693-9429","authenticated-orcid":false,"given":"Angela M.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-6868","authenticated-orcid":false,"given":"Mar\u00eda","family":"Luna-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7827-5250","authenticated-orcid":false,"given":"Diana","family":"Cuervo-Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-6911","authenticated-orcid":false,"given":"Guillermo E.","family":"Quintero-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Daza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-5130","authenticated-orcid":false,"given":"Olga Paola","family":"Oma\u00f1a-Orduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-164X","authenticated-orcid":false,"given":"William","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-9053","authenticated-orcid":false,"given":"Kenny","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-969X","authenticated-orcid":false,"given":"Laura Mar\u00eda","family":"D\u00edaz-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-0352","authenticated-orcid":false,"given":"Paola Andrea","family":"Guerrero-Burbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-6840","authenticated-orcid":false,"given":"Juan Manuel","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-5874","authenticated-orcid":false,"given":"Henry","family":"Idrobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-6971","authenticated-orcid":false,"given":"L M","family":"Gaviria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-3301","authenticated-orcid":false,"given":"Mario Ernesto","family":"Correa-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Lobat\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-3735","authenticated-orcid":false,"given":"Carlos Daniel","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-2469","authenticated-orcid":false,"given":"Julian Eduardo","family":"Pedraza-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-108X","authenticated-orcid":false,"given":"Juan Carlos","family":"Serrano-Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7242-6930","authenticated-orcid":false,"given":"Rigoberto","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Helena","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Var\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Rodr\u00edguez-Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mart\u00ednez-Cuadr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"6120_CR1","doi-asserted-by":"publisher","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u2013405. [Internet]. 2016 May 19 [cited 2023 Sep 25]; https:\/\/doi.org\/10.1182\/blood-2016-03-643544","DOI":"10.1182\/blood-2016-03-643544"},{"key":"6120_CR2","unstructured":"American Cancer Society Leucemia Mieloide Aguda (LMA) [Internet]. 2023 [cited 2023 Sep 16]. https:\/\/www.cancer.org\/es\/cancer\/tipos\/leucemia-mieloide-aguda\/acerca\/que-es-leucemia-mieloide-aguda.html"},{"issue":"2","key":"6120_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.blre.2016.09.005","volume":"31","author":"NA Podoltsev","year":"2017","unstructured":"Podoltsev NA, Stahl M, Zeidan AM, Gore SD (2017) Selecting initial treatment of acute myeloid leukaemia in older adults. Blood Rev 31(2):43\u201362","journal-title":"Blood Rev"},{"key":"6120_CR4","doi-asserted-by":"publisher","unstructured":"Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE et al (2006) Age and acute myeloid leukemia. Blood. [cited 2023 Sep 19];107(9):3481\u20135. https:\/\/doi.org\/10.1182\/blood-2005-09-3724","DOI":"10.1182\/blood-2005-09-3724"},{"issue":"22","key":"6120_CR5","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.3390\/cancers15225409","volume":"15","author":"A Alsouqi","year":"2023","unstructured":"Alsouqi A, Geramita E, Im A (2023) Treatment of acute myeloid leukemia in older adults. Cancers 15(22):5409. https:\/\/doi.org\/10.3390\/cancers15225409","journal-title":"Cancers"},{"key":"6120_CR6","doi-asserted-by":"crossref","unstructured":"Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH et al (2015) Clinical trials and observations: international phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >\u200930% blasts. Blood [Internet]. [cited 2023 Oct 11];126(3):291. Available from: \/pmc\/articles\/PMC4504945\/","DOI":"10.1182\/blood-2015-01-621664"},{"issue":"1","key":"6120_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS et al (2019) Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood 133(1):7\u201317","journal-title":"Blood"},{"issue":"11","key":"6120_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood.2019003988","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Tiong IS, Quaglieri A, MacRaild S, Loghavi S, Brown FC et al (2020) Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood 135(11):791\u2013803","journal-title":"Blood"},{"key":"6120_CR9","doi-asserted-by":"publisher","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. [cited 2022 Apr 19];129(4):424\u201347. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","DOI":"10.1182\/blood-2016-08-733196"},{"key":"6120_CR10","unstructured":"Pollyea DA, Altman JK, Chair V, Bixby D, Fathi AT, Foran JM et al (2023) NCCN Guidelines Versi\u00f3n 3.2023 Leucemia mieloide aguda (Edad\u2009\u2265\u200918 a\u00f1os) [Internet]. [cited 2023 Sep 25]. https:\/\/www.nccn.org\/home\/"},{"key":"6120_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05891-w","author":"A Solana-Altabella","year":"2024","unstructured":"Solana-Altabella A, Rodr\u00edguez-Veiga R, Mart\u00ednez-Cuadr\u00f3n D, Montesinos P (2024) A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold? Annals of hematology. https:\/\/doi.org\/10.1007\/s00277-024-05891-w","journal-title":"Annals of hematology"},{"key":"6120_CR12","volume-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para la detecci\u00f3n, tratamiento y seguimiento de leucemias linfobl\u00e1stica y mieloide en la poblaci\u00f3n mayor de 18 a\u00f1os","author":"Ministerio de Salud y Protecci\u00f3n Social","year":"2017","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (2017) Gu\u00eda de pr\u00e1ctica cl\u00ednica para la detecci\u00f3n, tratamiento y seguimiento de leucemias linfobl\u00e1stica y mieloide en la poblaci\u00f3n mayor de 18 a\u00f1os, 1st edn. Bogot\u00e1, Colombia","edition":"1"},{"key":"6120_CR13","first-page":"937","volume-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Vol. 114, Blood","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood J Am Soc Hematol 114: 937\u2013951"},{"key":"6120_CR14","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Cuadr\u00f3n D, Serrano J, Gil C, Tormo M, Mart\u00ednez-S\u00e1nchez P, P\u00e9rez-Sim\u00f3n JA et al (2021) Evolving treatment patterns and outcomes in older patients (\u2265\u200960 years) with AML: changing everything to change nothing? Leukemia. [cited 2023 Sep 25];35(6):1571\u201385. https:\/\/doi.org\/10.1038\/s41375-020-01058-4","DOI":"10.1038\/s41375-020-01058-4"},{"key":"6120_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2019.01.008","volume":"78","author":"JA Bell","year":"2019","unstructured":"Bell JA, Galaznik A, Farrelly E, Blazer M, Murty S, Ogbonnaya A et al (2019) A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7\u2009+\u20093 or a hypomethylating agent. Leuk Res 78:45\u201351","journal-title":"Leuk Res"},{"key":"6120_CR16","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.htct.2022.01.003","volume":"45","author":"JC Jaime-P\u00e9rez","year":"2023","unstructured":"Jaime-P\u00e9rez JC, Ramos-D\u00e1vila EM, Pic\u00f3n-Galindo E, Jim\u00e9nez-Castillo RA, De Le\u00f3n AG, G\u00f3mez-Almaguer D (2023) Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: data from a single center. Hematol Transfus Cell Ther 45:S43\u201350","journal-title":"Hematol Transfus Cell Ther"},{"key":"6120_CR17","unstructured":"Banco Mundial Datos de libre acceso del Banco Mundial [Internet]. 2022. https:\/\/datos.bancomundial.org\/. Accessed 11 Oct 2023"},{"issue":"4","key":"6120_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41375-021-01425-9","volume":"36","author":"C R\u00e9cher","year":"2022","unstructured":"R\u00e9cher C, R\u00f6llig C, B\u00e9rard E, Bertoli S, Dumas PY, Tavitian S et al (2022) Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. Leukemia 36(4):913\u2013922","journal-title":"Leukemia"},{"issue":"2","key":"6120_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3324\/haematol.2018.208637","volume":"105","author":"C Talati","year":"2020","unstructured":"Talati C, Dhulipala VC, Extermann M, Al Ali N, Kim J, Komrokji R et al (2020) Comparisons of commonly used front-line regimens on sur vival outcomes in patients aged 70 years and older with acute myeloid leukemia. Haematologica 105(2):398\u2013406","journal-title":"Haematologica"},{"issue":"18","key":"6120_CR20","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","volume":"113","author":"G Juliusson","year":"2009","unstructured":"Juliusson G, Antunovic P, Derolf \u00c5, Lehmann S, M\u00f6llg\u00e5rd L, Stockelberg D et al (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 113(18):4179\u20134187","journal-title":"Blood"},{"key":"6120_CR21","doi-asserted-by":"publisher","unstructured":"Nagel G, Weber D, Fromm E, Erhardt S, L\u00fcbbert M, Fiedler W et al (2017) Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO). Ann Hematol 96(12):1993\u20132003. https:\/\/doi.org\/10.1007\/s00277-017-3150-3","DOI":"10.1007\/s00277-017-3150-3"},{"issue":"10","key":"6120_CR22","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/ajh.25214","volume":"93","author":"EH Estey","year":"2018","unstructured":"Estey EH (2018) Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol 93(10):1267\u20131291","journal-title":"Am J Hematol"},{"issue":"5","key":"6120_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","volume":"98","author":"D Grimwade","year":"2001","unstructured":"Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ et al (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98(5):1312\u20131320","journal-title":"Blood"},{"issue":"4","key":"6120_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.36384\/01232576.683","volume":"27","author":"KM G\u00e1lvez-C\u00e1rdenas","year":"2023","unstructured":"G\u00e1lvez-C\u00e1rdenas KM, Enciso-Olivera LJ, Samanez-Figari CA, Quintana-Truyenque S, Castillo-R\u00edos BA, Quintero-Vega GE et al (2023) Treatment patterns and clinical outcomes in acute myeloid leukemia patients who are not eligible for intensive induction chemotherapy: a real-world study from Latin-America. Med Y Laboratorio 27(4):315\u2013332","journal-title":"Med Y Laboratorio"},{"issue":"1","key":"6120_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14740\/jh1055","volume":"12","author":"DM Mendoza-Urbano","year":"2023","unstructured":"Mendoza-Urbano DM, Tello-Cajiao ME, Rosales J, Ahumada FE, Parra-Lara LG, Arrieta E (2023) Survival in elderly patients diagnosed with acute myeloid leukemia: a hospital-based study. J Hematol 12(1):7\u201315","journal-title":"J Hematol"},{"issue":"Supplement 1","key":"6120_CR26","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2021-150649","volume":"138","author":"J Labrador","year":"2021","unstructured":"Labrador J, de la Fuente A, Mart\u00ednez-Cuadr\u00f3n D, Rodr\u00edguez-Veiga R, Serrano J, Tormo M et al (2021) Long-term subgroup analyses from azacitidine vs. decitabine in unfit newly diagnosed Acute myeloid leukemia patients: results from the Pethema registry. Blood 138(Supplement 1):1256\u20131256","journal-title":"Blood"},{"key":"6120_CR27","doi-asserted-by":"publisher","unstructured":"Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K et al Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood 135(24):2137. [Internet]. 2020 Jun 6 [cited 2023 Sep 28]; https:\/\/doi.org\/10.1182\/blood.2020004856","DOI":"10.1182\/blood.2020004856"},{"key":"6120_CR28","unstructured":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo (CAC) (2023) Situaci\u00f3n del c\u00e1ncer en la poblaci\u00f3n adulta atendida en el SGSSS de Colombia 2022; Bogot\u00e1, D.C. https:\/\/cuentadealtocosto.org\/publicaciones\/situacion-del-cancer-en-la-poblacion-adulta-atendida-en-el-sgsss-decolombia-2022\/"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06120-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06120-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06120-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:53:37Z","timestamp":1736978017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06120-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":28,"alternative-id":["6120"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06120-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5119261\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"General approval was obtained for the RENEHOC registry, and specific approval was granted by the Institutional Review Boards of each participating center. All procedures adhered to the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}